San Diego, CA – January 6, 2021 – Creo, an ingredient company with a proprietary platform for producing natural rare cannabinoids without the cannabis plant, today announced that it is participating in Biotech Showcase™ 2021 and providing an on-demand company presentation.
Roy Lipski, co-founder and CEO of Creo will hosting a presentation titled, “Nature Loves Our Cannabinoids. And So Will You,” at Biotech Showcase Digital, detailing the untapped potential of rarer cannabinoids, Creo’s fermentation process and an industry on the rise.
Creo is partnered with biotech industry-leader Genomatica to create a patented fermentation technology platform that allows it to produce consistent high-quality, rare cannabinoids, sustainably, at scale, and at a higher purity level than traditional methods.
“We are only at the beginning of what fermentation means for cannabinoid ingredients and industry disruption,” said Lipski. “We thank Biotech Showcase for inviting Creo to present to this influential group to discuss what our proprietary process will mean for everyone.”
“We are delighted that Creo will be presenting at Biotech Showcase this year,” said Sara Demy, CEO of Demy-Colton. “Biotech Showcase is a prime occasion for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery.”
About Biotech Showcase
Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year during the course of one of the industry's largest gatherings and busiest weeks.
About Creo
Creo is an ingredient company that produces rare and novel cannabinoids using the age-old natural process of fermentation, coupled with cutting-edge technological innovation. Founded in 2016 and based in California, Creo's mission is to enable the creation of cannabinoid products that help people everywhere while doing less harm to the planet. Creo's technology partner and major shareholder is industry-leading biotech firm Genomatica. To learn more, visit www.creoingredients.com.
